Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017)
Medicure (MCUJF) posted quarterly Non-Current Deferred Tax Liability of $478968.2 for Q4 2017, down 98.33% year-over-year from $28.6 million in Q4 2016, and down 98.14% quarter-over-quarter from $25.8 million in Q3 2017.
Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends
Medicure's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $478968.2 for Q4 2017.
- In Q4 2017, Non-Current Deferred Tax Liability fell 98.33% year-over-year to $478968.2; the TTM figure through Dec 2017 stood at $478968.2 (down 98.33% YoY), while the FY2017 annual figure was $469025.3, down 98.36% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2017 stood at $478968.2, down from $25.8 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $28.6 million in Q4 2016, with the low at $478968.2 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 478,968.19 |
| Dec 31, 2017 | 478,968.19 |
| Sep 30, 2017 | 25.78 Mn |
| Sep 30, 2017 | 25.78 Mn |
| Jun 30, 2017 | 26.25 Mn |
| Jun 30, 2017 | 26.25 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Dec 31, 2016 | 28.60 Mn |
| Dec 31, 2016 | 28.60 Mn |